Martin Brusdeilins
Plus aucun poste en cours
Profil
Martin Brusdeilins worked as the Chief Scientific Officer & Executive VP at Tecan Group AG from 2014 to 2014.
Prior to that, he was the VP-Product Development, Research & Development at Ortho-Clinical Diagnostics, Inc. from 2003 to 2011.
Brusdeilins holds a doctorate degree from Eberhard Karls Universität Tübingen.
Anciens postes connus de Martin Brusdeilins
| Sociétés | Poste | Fin |
|---|---|---|
| TECAN GROUP AG | Directeur des opérations | 14/07/2014 |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Directeur Technique/Scientifique/R&D | 01/01/2011 |
Formation de Martin Brusdeilins
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TECAN GROUP AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Health Technology |